Zantrene may respond to 15% of ALL CANCERS!
wow.... that's absolutely massive...
In 2020, the global oncology treatment spending totalled approximately $167 billion US, if Zantrene can be used in 15% of these treatments we're looking at potentially capitalising on approximately $25.5B annually. (Not to mention the global spending has grown from approx $74 bill USD just 6 years earlier!)
Obviously just back of the napkin type figures but wow, this seriously feels like a once in a lifetime opportunity...
Not sure how I'm supposed to sleep, every night will feel like the night before Christmas as a kid, potentially waking up to another massive present (announcement)
RACE: Marketing Blitz 2021-2022, page-89
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.02 |
Change
0.270(15.4%) |
Mkt cap ! $350.7M | |||
| Open | High | Low | Value | Volume |
| $1.87 | $2.08 | $1.86 | $1.234M | 628.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4200 | $1.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.96 | 5913 | 1 |
View Market Depth
| Last trade - 15.59pm 18/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.02 |
Change
0.270 ( 16.2 %) |
||||
| Open | High | Low | Volume | ||
| $1.86 | $2.08 | $1.86 | 50369 | ||
| Last updated 15.59pm 18/06/2024 ? | |||||
| RAC (ASX) Chart |